FRIDAY, Oct. 1, 2021 (HealthDay News) — One-quarter of U.S. parents report that their child has had to quarantine because of possible COVID-19 exposure since school started, a new poll finds. The nationally representative survey of 1,519 people conducted between Sept. 13 and Sept. 22 included 414 people who identifiedContinue Reading

FRIDAY, Oct. 1, 2021 (HealthDay News) — Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly afterContinue Reading

Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more Has the pandemic made the opioid epidemic worse? In interviews with HealthDayContinue Reading

FRIDAY, Oct. 1, 2021 (HealthDay News) — The COVID-19 pandemic has shaken up the U.S. opioid crisis in ways bad and good, increasing the risk of use and overdose but also spurring innovative approaches to treatment. The pandemic has definitely been linked to an increase in opioid use and overdoseContinue Reading